Wang Y - Search Results

1

Optimization of potent, selective and orally bioavailable biphenyl scaffold as FABP4 inhibitors for anti-inflammation.

He Y, Li S, Zhu Y, Wang Y, Chen Y, Zhang D, Wang H, Li Y. He Y, et al. Among authors: wang h, wang y. Eur J Med Chem. 2023 May 5;253:115319. doi: 10.1016/j.ejmech.2023.115319. Epub 2023 Apr 5. Eur J Med Chem. 2023. PMID: 37037141

2

Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents.

Yan Q, Wang Y, Zhang W, Li Y. Yan Q, et al. Among authors: wang y. Mar Drugs. 2016 Apr 28;14(5):85. doi: 10.3390/md14050085. Mar Drugs. 2016. PMID: 27136567 Free PMC article.

3

Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.

Ji YY, Lin SD, Wang YJ, Su MB, Zhang W, Gunosewoyo H, Yang F, Li J, Tang J, Zhou YB, Yu LF. Ji YY, et al. Eur J Med Chem. 2017 Dec 1;141:101-112. doi: 10.1016/j.ejmech.2017.09.073. Epub 2017 Oct 3. Eur J Med Chem. 2017. PMID: 29031059

4

Synthesis and biological evaluation of novel larotaxel analogues.

Ren S, Wang Y, Wang J, Gao D, Zhang M, Ding N, Li Y. Ren S, et al. Among authors: wang j, wang y. Eur J Med Chem. 2018 Aug 5;156:692-710. doi: 10.1016/j.ejmech.2018.07.029. Epub 2018 Jul 20. Eur J Med Chem. 2018. PMID: 30036834

5

Synthesis and biological evaluation of Ginsenoside Compound K analogues as a novel class of anti-asthmatic agents.

Ren S, Liu R, Wang Y, Ding N, Li Y. Ren S, et al. Among authors: wang y. Bioorg Med Chem Lett. 2019 Jan 1;29(1):51-55. doi: 10.1016/j.bmcl.2018.11.016. Epub 2018 Nov 9. Bioorg Med Chem Lett. 2019. PMID: 30448233

6

Identification and immunological evaluation of novel TLR2 agonists through structure optimization of Pam₃CSK₄.

Du X, Qian J, Wang Y, Zhang M, Chu Y, Li Y. Du X, et al. Among authors: wang y. Bioorg Med Chem. 2019 Jul 1;27(13):2784-2800. doi: 10.1016/j.bmc.2019.05.005. Epub 2019 May 6. Bioorg Med Chem. 2019. PMID: 31101493

7

Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities.

Xiao D, Wang YJ, Hu XB, Kan WJ, Zhang Q, Jiang X, Zhou YB, Li J, Lu W. Xiao D, et al. Eur J Med Chem. 2019 Aug 15;176:419-430. doi: 10.1016/j.ejmech.2019.05.035. Epub 2019 May 15. Eur J Med Chem. 2019. PMID: 31125896

8

Structural optimization and neurotrophic activity evaluation of neurotrophic gentiside derivatives.

Wang Z, Ma C, Wang Y, Xiao Q, Xu C, Li Y. Wang Z, et al. Among authors: wang y. Bioorg Med Chem Lett. 2019 Nov 15;29(22):126685. doi: 10.1016/j.bmcl.2019.126685. Epub 2019 Sep 13. Bioorg Med Chem Lett. 2019. PMID: 31607606

9

Structural optimization of aminopyrimidine-based CXCR4 antagonists.

Zhu F, Wang Y, Du Q, Ge W, Li Z, Wang X, Fu C, Luo L, Tian S, Ma H, Zheng J, Zhang Y, Sun X, He S, Zhang X. Zhu F, et al. Among authors: wang x, wang y. Eur J Med Chem. 2020 Feb 1;187:111914. doi: 10.1016/j.ejmech.2019.111914. Epub 2019 Nov 26. Eur J Med Chem. 2020. PMID: 31806538

10

Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.

Li Z, Wang X, Lin Y, Wang Y, Wu S, Xia K, Xu C, Ma H, Zheng J, Luo L, Zhu F, He S, Zhang X. Li Z, et al. Among authors: wang x, wang y. Eur J Med Chem. 2020 Nov 1;205:112537. doi: 10.1016/j.ejmech.2020.112537. Epub 2020 Jul 23. Eur J Med Chem. 2020. PMID: 32768738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272,132 results

Search Page